Abrdn Healthcare Investors

Form 4Def-14A

Insider Trading (Form 4)

NYSE
HQH
Abrdn Healthcare Investors
Form 4: abrdn Healthcare Investors Director Buys Shares
Chris Lavictoire Mahai, a Director of abrdn Healthcare Investors, purchased 501 shares of common stock on July 16, 2026 for $20.96 per share.
NYSE
HQH
Abrdn Healthcare Investors
Form 4: abrdn Healthcare Investors Director Rose DiMartino Acquires 1,000 Shares
Director Rose DiMartino purchased 1,000 shares of abrdn Healthcare Investors (HQH) at $18.88 per share on July 16, 2024.
NYSE
HQH
Abrdn Healthcare Investors
Form 4: Director Kathleen Goetz Acquires Additional Shares of abrdn Healthcare Investors (HQH)
Kathleen Goetz, a director of abrdn Healthcare Investors, recently purchased 525 shares of the company's common stock at a price of $16.4236 per share.

Proxy Statements (Def-14A)

NYSE
HQH
Abrdn Healthcare Investors
DEF: Abrdn Funds Announce Annual Meetings and Trustee Elections
Abrdn Healthcare Investors, Abrdn Life Sciences Investors, Abrdn Healthcare Opportunities Fund, and Abrdn World Healthcare Fund have issued a joint proxy statement detailing their upcoming annual shareholder meetings on May 27, 2026, primarily for the election of Trustees.
NYSE
HQH
Abrdn Healthcare Investors
DEF: Abrdn Healthcare Funds Announce Annual Shareholder Meetings to Elect Trustees
Abrdn Healthcare Investors, abrdn Life Sciences Investors, abrdn Healthcare Opportunities Fund, and abrdn World Healthcare Fund will hold annual shareholder meetings on May 28, 2025, to elect trustees.
NYSE
HQH
Abrdn Healthcare Investors
DEF 14A: Abrdn Healthcare Funds Announce Annual Shareholder Meetings to Elect Trustees
Abrdn Healthcare Investors, Abrdn Healthcare Opportunities Fund, and Abrdn World Healthcare Fund will hold annual shareholder meetings on June 25, 2024, to elect trustees.